Eating oranges may prevent eye disease: Study

Image
Press Trust of India Melbourne
Last Updated : Jul 13 2018 | 12:55 PM IST

People who regularly eat oranges are less likely to develop macular degeneration - the leading cause of vision loss, a study led by an Indian origin researcher claims.

Researchers at the Westmead Institute for Medical Research in Australia interviewed more than 2,000 adults aged over 50 and followed them over a 15-year period.

Macular degeneration is a medical condition which may result in blurred or no vision in the centre of the visual field.

The study, published in the American Journal of Clinical Nutrition, showed that people who ate at least one serving of oranges every day had more than a 60 per cent reduced risk of developing late macular degeneration 15 years later.

Lead researcher Bamini Gopinath, an associate professor at the University of Sydney, said the data showed that flavonoids in oranges appear to help prevent against the eye disease.

"Essentially we found that people who eat at least one serve of orange every day have a reduced risk of developing macular degeneration compared with people who never eat oranges," she said.

"Even eating an orange once a week seems to offer significant benefits. The data shows that flavonoids found in oranges appear to help protect against the disease," Gopinath said.

Until now most research has focused on the effects of common nutrients such as vitamins C, E and A on the eyes.

"Our research is different because we focused on the relationship between flavonoids and macular degeneration, she said.

Flavonoids are powerful antioxidants found in almost all fruits and vegetables, and they have important anti-inflammatory benefits for the immune system.

"We examined common foods that contain flavonoids such as tea, apples, red wine and oranges. Significantly, the data did not show a relationship between other food sources protecting the eyes against the disease," Gopinath said.

Age is the strongest known risk factor for macular degeneration and the disease is more likely to occur after the age of 50. There is currently no cure for the disease, the researchers said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 13 2018 | 12:55 PM IST

Next Story